Skip to main content
Premium Trial:

Request an Annual Quote

Personalis Prices $150M Public Stock Offering

NEW YORK – Personalis said Wednesday that it has priced a public offering of 3,950,000 shares of its common stock at $38 per share.

The Menlo Park, California-based firm expects gross proceeds from the offering to be about $150 million. It also is granting underwriters a 30-day option to purchase up to an additional 592,500 shares under the same terms and conditions.

Morgan Stanley, BofA Securities, Citigroup and Cowen are acting as joint book-running managers. BTIG is acting as co-manager.

Personalis, which has commercialized a suite of next-generation sequencing services for population genomics, cancer research, and diagnostics, said it would use proceeds from the offering for working capital and general corporate purposes.

In Wednesday morning trade on the Nasdaq, shares of Personalis were down around 10 percent at $38.43.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.